Product Images Gabapentin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Gabapentin NDC 68788-8712 by Preferred Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - image 01

This text seems to provide information about a pain study, including the mean pain score at baseline and at weeks, as well as the dosages of two different treatments being evaluated. It mentions a placebo group and a group receiving 3600 mg/day of Gabapentin.*
Figure 2 - image 02

This text describes a pain study where participants were given different doses of Gabapentin (a medication commonly used for nerve pain) or a placebo over a 4-week period. The pain scores were measured at baseline and weekly for 7 weeks to evaluate the effectiveness of different doses of Gabapentin in reducing pain levels.*
Figure 3 - image 03

This text provides information on the proportion of responders (patients with at least a 50% reduction in pain score) at the endpoint of controlled post-herpetic neuralgia (PHN) studies. The results are shown for Study 1 and Study 2, comparing different treatment groups such as placebo (PBO), GBP 3600, GBP 1800, and GBP 2400. The statistical significance is indicated with p-values.*
image-09 - image 09

This text appears to show a chart or table related to daily dose measurement in milligrams (mg). The chart includes various values and possibly has different columns or sections. The maximum dose mentioned is 1600 mg. The specific context or purpose of the data is not provided.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.